Plus: Justice Department reclassifies marijuana products

April 27, 2026

1. What's broken in the pharmacy tech pipeline — and how leaders would repair it Full story

2. Johnson & Johnson to add 4 drugs to TrumpRx Full story

3. Hear 90+ pharmacy executives discuss cost, workforce & clinical integration here.

 

4. Last major drugmaker joins Trump pricing deals Full story

5. FDA approves 1st gene therapy for genetic hearing loss Full story

6. Pharmacy leaders are rethinking procurement. Their approach to reducing risk and protecting margins here.

 

7. Justice Department reclassifies marijuana products: What it means for healthcare Full story

8. Mark Cuban's Cost Plus Drugs lands Eliquis deal Full story

9. Bariatric surgery volumes continue falling amid GLP-1 boom Full story

10. Bipartisan House bill targets MA prior authorization, denial practices: 5 notes Full story

11. Hospitals' $1.6 trillion cost crisis: 10 things to know Full story

 

12. Jefferson Health, Ochsner, Tampa General share new models for throughput and capacity optimization here.

Becker's Learning Opportunities

13. Baptist Health Arkansas reduced avoidable days 25%. See what changed here.

14. Margin now depends on integrated data across sites of care. Leaders explain how here.

15. ED left-without-being-seen rates dropped. Patient satisfaction climbed. See the access strategy behind it here.

16. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication